{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:30:56Z","timestamp":1773696656753,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.bmc.2018.11.036","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T13:33:41Z","timestamp":1543325621000},"page":"1449-1455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages"],"prefix":"10.1016","volume":"27","author":[{"given":"P.A.F.","family":"Pacheco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.S.","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.M.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.l.","family":"Von Ranke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.l.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.F.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.R.","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.X.","family":"Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2018.11.036_b0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10863-015-9613-0","article-title":"Fluorescent dyes as a reliable tool in P2X7 receptor-associated pore studies","volume":"47","author":"Ferreira","year":"2015","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.bmc.2018.11.036_b0010","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1016\/S0021-9258(18)47497-2","article-title":"ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes","volume":"262","author":"Steinberg","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2018.11.036_b0015","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3389\/fimmu.2017.01529","article-title":"Modulation of P2X7 receptor during inflammation in Multiple sclerosis","volume":"8","author":"Amadio","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2018.11.036_b0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmc.2018.11.036_b0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5314\/wjd.v5.i2.72","article-title":"P2X7 receptor in skin biology and diseases","volume":"5","author":"Geraghty","year":"2016","journal-title":"World J Dermatol"},{"key":"10.1016\/j.bmc.2018.11.036_b0030","first-page":"6","article-title":"Role of P2X7 receptors in release of IL-1\u03b2: a possible mediator of pulmonary inflammation","volume":"11","author":"Mortaz","year":"2012","journal-title":"Tanaffos"},{"key":"10.1016\/j.bmc.2018.11.036_b0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2125.2012.04320.x","article-title":"Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects","volume":"75","author":"Ali","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2018.11.036_b0040","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"D1520C00001 Study Team. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bmc.2018.11.036_b0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bmc.2018.11.036_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4155\/ppa-2016-0044","article-title":"P2X7 antagonists for CNS indications: recent patent disclosures","volume":"6","author":"Pevarello","year":"2017","journal-title":"Pharm Pat Anal"},{"key":"10.1016\/j.bmc.2018.11.036_b0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ejmech.2017.08.034","article-title":"1-Aryl-1H- and 2-aryl-2H-1,2,3-triazole derivatives blockade P2X7 receptor in vitro and inflammatory response in vivo","volume":"139","author":"Gonzaga","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.11.036_b0060","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1002\/chem.200700823","article-title":"Total synthesis of the proposed structure of the anthrapyran metabolite delta-indomycinone","volume":"13","author":"Tietze","year":"2007","journal-title":"Chemistry"},{"key":"10.1016\/j.bmc.2018.11.036_b0065","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1039\/c1ob05209h","article-title":"Synthesis of new 9-hydroxy-a- and 7-hydroxy-b-pyran naphthoquinones and cytotoxicity against cancer cell lines","volume":"9","author":"da Rocha","year":"2011","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2018.11.036_b0070","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ejmech.2017.10.033","article-title":"1,4-Naphthoquinones potently inhibiting P2X7 receptor activity","volume":"143","author":"Faria","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.11.036_b0075","unstructured":"Marvin Sketch (version 6.2.2, calculation module developed by ChemAxon, http:\/\/www.chemaxon.com\/products\/marvin\/marvinsketch\/, 2014."},{"key":"10.1016\/j.bmc.2018.11.036_b0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"molecular force field. I. Basis, form, scope, arameterization, and performance of MMFF94","volume":"17","author":"Merck","year":"1996","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2018.11.036_b0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jcc.20425","article-title":"RM1: a reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I","volume":"27","author":"Rocha","year":"2006","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2018.11.036_b0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2018.11.036_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086806","article-title":"Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models","volume":"9","author":"Novakova","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2018.11.036_b0100","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"pii","author":"Karasawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bmc.2018.11.036_b0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/157488910789753530","article-title":"Recent patents on novel P2X7 receptor antagonists and their potential for reducing central nervous system inflammation","volume":"5","author":"Friedle","year":"2010","journal-title":"Recent Pat CNS Drug Discov"},{"key":"10.1016\/j.bmc.2018.11.036_b0110","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.bmcl.2008.01.095","article-title":"Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists","volume":"18","author":"Florjancic","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2018.11.036_b0115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","article-title":"Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors","volume":"157","author":"Donnelly-Roberts","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2018.11.036_b0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2009.05.018","article-title":"The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice","volume":"204","author":"Honore","year":"2009","journal-title":"Behav Brain Res"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618314159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618314159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:59:49Z","timestamp":1760835589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089618314159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0968089618314159"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2018.11.036","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2018.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}